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In Brief
Neutrophils are required to meet their
energy demands at inflamed sites where
nutrients may be limited. Sadiku et al.
provide evidence of a specialized
metabolism that enables neutrophils to
utilize glycogen cycling for energy
production. This is essential for
neutrophil function and survival, and
dysregulation is associated with chronic
disease states..
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SUMMARY
Neutrophils can function and survive in injured and infected tissues, where oxygen andmetabolic substrates
are limited. Using radioactive flux assays and LC-MS tracingwith U-13C glucose, glutamine, and pyruvate, we
observe that neutrophils require the generation of intracellular glycogen stores by gluconeogenesis and
glycogenesis for effective survival and bacterial killing. These metabolic adaptations are dynamic, with net
increases in glycogen stores observed following LPS challenge or altitude-induced hypoxia. Neutrophils
from patients with chronic obstructive pulmonary disease have reduced glycogen cycling, resulting in
impaired function. Metabolic specialization of neutrophils may therefore underpin disease pathology and
allow selective therapeutic targeting.
INTRODUCTION
Neutrophils are the most abundant leukocyte, constituting
around 60% of the circulating pool. These short-lived cells are
the first to accumulate at inflamed tissues where their primary
role is to phagocytose and degrade invading pathogens. The
requirement to access ATP rapidly to enable an effective host
pathogen response places very specific energy requirements
upon these cells. In diseases such as chronic obstructive pulmo-
nary disease (COPD), dysfunctional neutrophilic inflammation is
associated with impaired pathogen control and prolonged
inflammation, which contribute significantly to pathology (Desai
et al., 2014; Hogg et al., 2004). Changes in metabolic flux have
been associated with murine macrophage polarization and
T cell receptor activation, with associated alteration of immune
cell function (Mills et al., 2016; Tyrakis et al., 2016). How neutro-
phils dynamically regulate metabolic pathways to fuel antimicro-
bial responses in the tissues where nutrient supply may be
limited remains an important question in the field.
The existing dogma regarding neutrophil metabolism dates
from in vitro studies in the 1950s, detailing the importance of
glucose-fueled glycolysis for phagocytosis and respiratory burst
activity (Borregaard and Herlin, 1982; Sbarra and Karnovsky,
1959). Neutrophils cultured in glucose-enriched media utilized
extra-cellular glucose for glycolysis and had very low rates of
oxidative phosphorylation, in keeping with observations that
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Figure 1. Neutrophil Stimulation Results in Upregulated Glycolytic and PPP Activity, Redox Buffer Capacity, and Glutamine Utilization
(A–C) Radioactive flux assay analysis of human neutrophils following 6 h of culture showing glycolysis (A), TCA/PPP cycle (B), and fatty acid oxidation (FAO) (C) in
unstimulated and stimulated neutrophils under normoxic (N, 21%O2, white bar) and hypoxic (H, 1%O2, gray bar) culture. (A) N and N + LPS, n = 12; N + 2-DG, n =
6; N + LPS + 2-DG, n = 4; H and H + LPS, n = 11; H + 2-DG, n = 5; H + LPS + 2-DG, n = 3. (B) n = 4 for all conditions. (C) N and N + LPS, n = 6; H and H + LPS, n = 5;
N + etomoxir and H + etomoxir, n = 3.
(legend continued on next page)
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inhibition of oxidative phosphorylation has little effect on neutro-
phil oxygen consumption or reactive oxygen species (ROS) pro-
duction (Fossati et al., 2003), whereas inhibition of glycolysis us-
ing 2-deoxyglucose (2-DG) severely impairs their phagocytic and
bacterial killing functions (Boxer et al., 1977). More recently,
studies of human and murine deficiencies in the G6P transporter
and G6Pase-b, respectively, have reported that defective intra-
cellular glucose cycling can also impact key neutrophil functions.
In these settings, impaired glucose shuttling between the endo-
plasmic reticulum and cytoplasm results in neutropenia and de-
fects in respiratory burst activity, ATP production, and bacterial
killing (Cheung et al., 2007; Jun et al., 2012; Kim et al., 2008).
There is also evidence, however, that a disproportionate in-
crease in glycolysis fuels neutrophil persistence in inflamed air-
ways, resulting in lung injury and death (Sadiku et al., 2017). Neu-
trophils must therefore tightly regulate glucose utilization and
flux through glycolysis to match energy provision to the immedi-
ate energy demands of a proportionate but effective host
response.
Neutrophil dependence upon glycolysis allows these cells to
function and survive at inflamed sites, where limited oxygen
availability may render oxidative metabolism ineffective at
meeting energy demand. Since extracellular glucose may also
be limited at inflamed sites (Garnett et al., 2012; Naughton
et al., 1993), we questioned whether neutrophils have a more
complex metabolism than previously thought to ensure they
can meet energy demand independently of immediate extracel-
lular substrate availability. In this regard, it is interesting to note
that neutrophils have been shown to contain glycogen within
granules, with early evidence that neutrophil glycogen stores
can be modified between circulating and recruited cells, by acti-
vation of the oxygen sensing response, and by stimulation with
proinflammatory mediators (Robinson et al., 1982; Sadiku
et al., 2017; Scott, 1968; Valentine et al., 1953). In this work,
we define the metabolic programs that enable neutrophils to
generate intra-cellular energy stores and retain function and sur-
vival responses under conditions of physiological stress and
activation. Further, we demonstrate dysregulation of these
metabolic processes in chronic inflammatory disease, with con-
sequences for neutrophil function and survival.
RESULTS
Pro-inflammatory Mediators Increase Neutrophil
Glycolytic Flux, Redox Buffering Capacity, and
Glutamine Utilization
We used radioactively labeled substrates to characterize which
metabolic pathways neutrophils utilize in basal and LPS-stimu-
lated states under conditions of both normoxia and hypoxia (Fig-
ures 1A–1C). In keeping with the literature, we observed unsti-
mulated neutrophils to be highly glycolytic, with equivalent
glycolytic capacity in normoxia and hypoxia (Figure 1A). LPS
stimulation significantly increased glycolytic flux, and this could
be reversed by inhibition of glycolysis with 2-DG (Figure 1A).
Although detectable levels of glucose oxidation and pentose
phosphate pathway (PPP) activity were seen, these were 100-
fold less than flux observed through glycolysis (Figure 1B). While
at baseline neutrophils had a relatively high level of fatty acid
oxidation (FAO), this was suppressed by LPS stimulation (Fig-
ure 1C). Metabolic pathways required for ATP and redox are
summarized in Figure 1D. To more specifically delineate the ef-
fects of physiological stressors on these pathways, we under-
took liquid chromatography-mass spectrometry (LC-MS) quan-
tification of individual metabolic intermediaries. We observed
that LPS increased relative abundance of key glycolytic metab-
olites, glucose-6-phosphate/fructose-6-phosphate (Figure 1E),
dihydroxyacetone phosphate (DHAP) (Figure 1F), glyceralde-
hyde-3-phosphate (Figure 1G), and lactate (Figure 1H). In addi-
tion, levels of the PPP substrates ribose-5-phosphate (Figure 1I)
and sedoheptulose-7-phosphate (Figure 1J), an important
branch pathway of glycolysis that enables neutrophil respiratory
burst activity (Bender and Van Epps, 1985), were also induced in
response to LPS. In keeping with the increased flux through the
PPP and therefore redox buffering capacity, LPS stimulation also
significantly increased levels of NADPH and NADH under hypox-
ic culture (Figures 1K and 1L). Given that neutrophil supplemen-
tation with glutamine has previously been described to promote
neutrophil phagocytosis, we also analyzed glutamine availability
in un-stimulated and stimulated neutrophils under hypoxic and
normoxic culture. Although we were unable to detect a signifi-
cant increase in the total abundance of glutamine in response
to LPS (Figure 1M), we found that LPS upregulated glutamine
conversion into glutamate (Figure 1N), indicative of increased
glutamine utilization in LPS-stimulated neutrophils.
Favorable Neutrophil Energetics Are Maintained by
Glycolysis under Conditions of Physiological Stress
Radioactive flux assay data were used to predict the relative
contribution of FAO, oxidative phosphorylation via the tricarbox-
ylic acid (TCA) cycle, and glycolysis to neutrophil production of
ATP (De Bock et al., 2013). These calculations supported glycol-
ysis contributing a significantly higher proportion of ATP produc-
tion to neutrophils than FAO under both normoxic and hypoxic
culture and following LPS stimulation (Figures 2A and 2B). To
validate these calculations, we measured the energy status of
neutrophils (ATP/ADP ratio) in the presence of chemical inhibi-
tors of glycolysis (2-DG) (Figure 2C), FAO (etomoxir) (Figure 2D),
and oxidative phosphorylation (oligomycin A) (Figure 2E)
(D) A pathway diagram showing the metabolites measured in human neutrophils following 6 h of culture in normoxia and hypoxia in the presence or absence of
LPS stimulation.
(E–L) LC-MS analyses of the neutrophil intracellular abundance of glycolytic metabolites (glucose-6-phosphate/fructose-6-phosphate, G6P/F6P; dihydroxy-
acetone phosphate, DHAP; glyceradehyde-3-phosphate, GAP; lactate), pentose phosphate pathway metabolites (PPP; ribose-5-phosphate/xylulose-5-phos-
phate, R5P/X5P; sedoheptulose-7-phosphate, S7P), and redox buffers (NADPH and NADH). n = 3.
(M and N) LC-MS time course analyses of the neutrophil intracellular levels of amino acid glutamine (M; n = 3) and percentage heavy labeled glutamate (N; n = 3)
following culture with U-13C glutamine.
Data represent mean ± SEM. p values obtained via unpaired t tests (A–C), paired t tests (D–L), or two-way ANOVAwith Tukey’s multiple comparisons test; overall
significance shown for increase in labeled glutamate from 2 to 6 h (N). *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001.
ll
OPEN ACCESSArticle
Cell Metabolism 33, 1–13, February 2, 2021 3
Please cite this article in press as: Sadiku et al., Neutrophils Fuel Effective Immune Responses through Gluconeogenesis and Glycogenesis, Cell Meta-
bolism (2020), https://doi.org/10.1016/j.cmet.2020.11.016
(Neubert and Lehninger, 1962; Pike et al., 2011; Wick et al.,
1957). Only treatment of neutrophils with the hexokinase inhibitor
2-DG resulted in a failure of neutrophils to maintain their high en-
ergy status, independent of oxygen availability (Figures 2C–2E).
It is important to note that 2-DG may be exerting off-target ef-
fects through inhibition of N-glycosylation and induction of the
unfolded protein response (Yu and Kim, 2010). To assess
whether neutrophils have the capacity to actively maintain favor-
able energetics, we measured relative levels of ATP, ADP, and
AMP over time, and determined the energy charge ([ATP + 1/
2ADP]/[ATP + ADP + AMP]) of neutrophils under conditions of
hypoxia, glucose deprivation, and LPS stimulation. Neutrophils
were able to maintain their energetic balance across multiple
time points (Figure 2F) even when oxygen and glucose were
limited (Figures 2G and S1A–S1C). Neutrophils are therefore
adept at maintaining intracellular energy homeostasis both in
quiescent and activated states, throughout their lifespan, and
despite the presence of physiological stresses including glucose
and oxygen deprivation, provided they can maintain an active
glycolytic pathway.
Intracellular Glycogen Stores Are Essential for
Neutrophil Survival
Havingdemonstrated neutrophil relianceonglycolysis, even in the
absence of extra-cellular glucose, we next questioned whether
neutrophils canmeet their energy demands by generating and uti-
lizing intracellular glucose stores in the form of glycogen.
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Figure 2. Neutrophil ATP Is Predominantly
Generated by Glycolysis with Maintenance
of Energy Charge during Neutrophil Life-
span and in a Glucose-Deplete Setting
(A and B) ATP contribution of fatty acid oxidation
(FAO), tricarboxylic acid cycle (TCA), and glycol-
ysis were derived from calculation from the radio-
active flux assays comparing normoxia to hypoxia
(A) and unstimulated to LPS-stimulated neutro-
phils following 6 h of culture (B). Normoxia, FAO,
n = 6; TCA, n = 3; glycolysis, n = 9; hypoxia, FAO,
n = 4; TCA, n = 3; glycolysis, n = 8: normoxia + LPS,
FAO, n = 6; TCA, n = 3; glycolysis, n = 9.
(C–E) Energy status measurement (ATP/ADP) of
neutrophils cultured for 2 h in the presence
and absence of pathway inhibitors 10 mM 2-DG
(C; n = 4), 1.2 mMoligomycin A (D; n = 3), and 10 mM
etomoxir (E; n = 3).
(F and G) Energy charge measurement ([ATP +
1/2ADP]/[ATP + ADP + AMP]) in neutrophils
cultured for 2, 6, and 20 h in normoxia and hypoxia
(F) and for 12 h in glucose-replete and -deplete
medium in unstimulated and LPS-stimulated cells
(G). (F) normoxia + LPS-glucose, n = 4; hypoxia +
glucose, n = 3. (G) n = 3.
Data represent mean ± SEM. p values obtained via
unpaired t test (A and B) or paired t test (C). *p <
0.05, **p < 0.01, ***p < 0.005, ****p < 0.001.
Glycogen levels in unstimulated and LPS-
stimulated cells were measured under
conditions of normoxia and hypoxia.
LPS-stimulated neutrophils had signifi-
cantly higher levels of glycogen in both
normoxia and hypoxia (Figure 3A). Inhibiting glycogen degrada-
tion using the glycogen phosphorylase inhibitor CP-91149 (Martin
et al., 1998) increased intracellular glycogen content (Figure 3B),
and the resulting inability of neutrophils to access glycogen stores
led to impaired neutrophil survival in glucose-deprived cultures of
both non-LPS- and LPS-treated cells (Figure 3C).
Neutrophils Use Gluconeogenesis to Generate
Glycolytic Intermediaries from Non-glucose Substrates
to Increase Their Glycolytic Capacity
Combining the ability of neutrophils to fuel glycolysis and main-
tain energy states in glucose-deplete conditions with their ability
to regulate intracellular glycogen led us to question whether neu-
trophils can utilize glucose and non-glucose substrates to
generate glycogen stores. We first verified that neutrophils regu-
late glycogenesis by demonstrating increased uptake of U-14C
glucose and higher levels of radioactively labeled glycogen
following LPS challenge (Figure 3D). Importantly, when neutro-
phils were cultured with U-14C lactate, we were again able to
detect significant levels of radioactivity in the purified glycogen
(Figure 3E), indicating that neutrophils can use non-glucose sub-
strates to generate glycogen stores. In keeping with the ability of
neutrophils to undergo glycogenesis and gluconeogenesis, we
observed that neutrophils express key enzymes required for
active glycogenesis (GYS1, GBE1, and UGP2) and gluconeo-
genesis (FBP1 and PEPCK2) at both mRNA and protein levels
(Figures 3F and 3G).
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To confirm that neutrophils have the capacity for gluconeogen-
esis, cells were incubated with heavy U-13C glucose, U-13C gluta-
mine, andU-13Cpalmitate tracers, andanalysisof 13C labelingwas
quantified by LC-MS. A schematic detailing the putative entry and
cyclingofcarbonmolecules fromU-13Cglucose (blackcircles) and
U-13C glutamine (gray circles) into TCA and glycolytic isotopo-
logues is provided in Figure 3H. Detection of multiple isotopo-
logues of glucose-6-phosphate/fructose-6-phosphate following
neutrophil culture with U-13C glucose (Figure 3I) and the presence
of heavy carbons within glycolytic and TCA intermediaries
following neutrophil culture with U-13C glutamine (Figures 3J–3L)
and U-13C palmitate (Figure 3M) together provide definitive evi-
dence for active neutrophil gluconeogenesis. The ability of neutro-
phils to inducegluconeogenicactivitywasobservedwithbothLPS
treatment (Figures 3I–3L) and in hypoxia (Figures 3J–3L), with
higher levels of labeled carbons fromglutamine observed in glyco-
lytic intermediaries (Figure 3J). Thus, glutamine contributes to the
increase in gluconeogenesis observed in response to hypoxia and
LPS. The full isotopologue profiles for citrate/isocitrate, oxaloace-
tate, malate, pyruvate, and F1,6BP following neutrophil culture for
4 h with U-13C glutamine are shown in Figures S2A–S2F, with sig-
nificant differences in substrate utilization observed within 2 h of
U-13C glutamine supplementation (Figures S3A–S3F). Increased
tracing of U-13C glutamine carbons into PPP metabolites was
alsoobservedwithLPSstimulation (FiguresS4AandS4B). Inorder
todirectlyassesswhethergluconeogenesiscontributes to thesyn-
thesis of glycogen, we undertook the tracing of heavy carbons
from pyruvate into glycogen. 13C-labeled glucose generated
from hydrolyzed glycogen was observed in LPS-stimulated neu-
trophils (Figure 3N), providing direct evidence for a role of gluco-
neogenesis in fueling glycogen synthesis.
Glycogen Storage Capacity Dictates Neutrophil
Function and Survival
With evidence for dynamic regulation of both gluconeogenesis
and glycogenesis, we questioned the interplay between these
pathways and their importance for neutrophil function and sur-
vival. Culture of LPS-stimulated neutrophils with the glutaminase
inhibitor BPTES significantly reduced intracellular glycogen levels,
supporting a role for glutaminolysis in the synthesis of glycogen
(Figure 4A). Furthermore, neutrophil intracellular glycogen levels
were also significantly reduced following inhibition of gluconeo-
genesis (FBP1) with the inhibitor MB05032 (Figure 4B). The func-
tional consequence of limiting glutamine access and blocking
gluconeogenesis was next explored. Glutamine deprivation and
inhibition of either PEPCK (3-mercaptopicolinic acid, 3-MPA) or
FBP1 (FBPi or MB05032) resulted in reduced neutrophil survival
(Figures 4C–4E). Neutrophils also displayed defective bacterial
killing when gluconeogenesis (Figure 4F) and glutaminolysis (Fig-
ure 4G) were disrupted. To directly test whether gluconeogenesis
and glycogen shuttling regulate neutrophil function in vivo, we
generated a neutrophil-specific glycogen synthase (Gys1)
knockout mouse (Figures S5A and S5B). Targeting GYS1, the
dominant isoform in neutrophils, enabled us to prevent the gener-
ation of glycogen in neutrophils, therefore abrogating the
glycogen shuttle. Gys1loxloxMRP8-cre+/ mice demonstrated no
baseline defect in blood neutrophil numbers (Figure S5C) or
monocyte proportion (Figure S5D). Airspace neutrophils were iso-
lated from mice 24 h post-LPS challenge, and the consequences
of GYS1 loss for apoptosis and bacterial killing were assessed
ex vivo. In order to identify the neutrophil niche in which glycogen
is most important, glycogen was first measured in bone marrow
(BM), blood, and bronchoalveolar lavage (BAL) neutrophils. We
found that glycogen levels in the BM and circulating neutrophils
of naive and LPS-challenged wild-type (WT) mice are significantly
lower than those of BAL neutrophils recruited following LPS chal-
lenge (Figure 4H). Subsequent assessment of glycogen content in
blood and airspace neutrophils from Gys1loxloxMRP8-cre+/ and
Gys1loxloxMRP8-cre/ mice 24 h post-LPS challenge confirmed
that Gys1 loss results in a significant reduction in levels of
glycogen in these cells (Figure 4I). In vitro, this translated into func-
tional consequences shown by an increase in apoptosis
Figure 3. Regulation of Glycogen Stores and Gluconeogenesis Pathway Activity during Human Neutrophil Activation
(A) Glycogen level quantification in freshly isolated neutrophils (0 h) and following 6 h of culture in glucose-deplete and -replete media under normoxia and
hypoxia. n = 4.
(B) Glycogen content of neutrophils following 6 h of normoxic culture with the glycogen phosphorylase inhibitor CP-91149 preventing glycogen breakdown. n = 4.
(C) Assessment of apoptosis rates using flow cytometry following culture in glucose-deprived media under normoxia and hypoxia with CP-91149 and LPS for
12 h. n = 5.
(D and E) Liquid scintillation count measurement of radioactive U-14C glucose (D; n = 4) and U-14C lactate (E; n = 5) incorporation into neutrophil glycogen stores
following 6 h of culture.
(F) Transcript expression of glycogenmetabolism and gluconeogenesismachinery: muscle glycogen synthase (GYS1, n = 4), glycogen branching enzyme (GBE1,
n = 4), UDP-glucose pyrophosphorylase 2 (UGP2, n = 3), liver glycogen phosphorylase (PYGL, n = 4), fructose-1,6-bisphosphatase 1 (FBP1, n = 4), and
phosphoenolpyruvate carboxykinase 2 (PEPCK2, n = 4).
(G) Protein expression of glycogenmetabolism and gluconeogenesis machinery in freshly isolated neutrophils (0 h) and neutrophils cultured for 6 or 20 h. Positive
controls for FBP1 and PEPCK2MCF7 lysate, PYGLmouse liver lysate, phospho-GYS (p-GYS), and GYS NIH/3T3 cell lysate. Representative western blots
are shown. n = 3.
(H) Diagrammatic representation of U-13C glucose (black circles) and U-13C glutamine (gray circles) labeling in human neutrophils. GNG, gluconeogenesis.
(I) G6P/F6P isotopologue abundance following culture in U-13C glucose media for 4 h under conditions of normoxia, normoxia with LPS, and hypoxia. n = 4.
(J–L) 13C percentage labeling of glycolytic intermediaries (J; n = 4) and isotopologue labeling of TCA cycle and glycolytic intermediaries (K and L; n = 4) following
4 h of culture in U-13C glutamine containing media.
(M) Percentage heavy labeling of G6P/F6P following 4 h of culture in the presence of U-13C palmitic acid. n = 4.
(N) Schematic diagram and relative abundance of glucose m+3 isotopologue following U-13C pyruvate tracing in neutrophils derived by LC-MS analysis of
hydrolyzed glycogen. n = 4.
Data represent mean ± SEM. Statistical significance was determined by paired t tests (A, B, and D) or two-way ANOVA with Tukey’s multiple comparisons test (C
and J–L) and a one-way ANOVAwith Tukey’s multiple comparisons test (N). *p < 0.05, **p < 0.01, ***p < 0.005. (J) Significance shown for unstimulated versus LPS
stimulated cells across all isotopologues.
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(Figure 4J) and reduced bacterial killing (Figure 4K). Impor-
tantly, Gys1loxloxMRP8-cre+/ mice revealed an impaired host
response following in vivo challenge with subcutaneous adminis-
tration of Staphylococcus aureus (Figures 4L–4N). Systemically,
these mice developed a significant degree of hypothermia (Fig-
ure 4L), with increased bacterial counts within the skin abscess
24 h following bacterial challenge (Figure 4M), and reduced circu-
lating neutrophil and monocyte numbers (Figures 4N and S5E).
With evidence that glycogen shuttling is important for neutro-
phil-mediated host responses, we questioned whether changes
in glycogen stores had long-term consequences for neutrophil
survival. Recent work from our group has shown that sustained
exposure of mice to systemic hypoxia reprograms neutrophil
glucose utilization (Thompson et al., 2017), and that activation
of oxygen sensing responses can alter neutrophil glycogen
stores (Sadiku et al., 2017). We therefore hypothesized that
exposure of healthy human volunteers to altitude-induced hyp-
oxia would enhance the capacity for activated neutrophils to
generate glycogen stores with long-term consequences for
neutrophil survival. Twelve healthy human volunteers were
exposed to 7 days of altitude-induced hypoxia (Figures S5F
and S5G) and their peripheral blood neutrophils were isolated
at baseline (BL), at altitude, and 3 months post altitude (PA),
then cultured in the presence or absence of LPS. Altitude expo-
sure resulted in significantly increased neutrophil glycogen
stores following LPS stimulation (Figure 4O), driven by induction
of UGP2 and glycogen synthaseGYS1 (Figures 4P, 4Q, S5H, and
S5I). This inflammatory uplift in glycogen stores following altitude
exposure was paralleled by enhanced neutrophil survival re-
sponses when compared to baseline (Figures 4R, S5K, and S5L).
Defective Induction of Gluconeogenesis and Reduced
Glycogen Cycling Impairs Neutrophil Function in COPD
Disordered neutrophilic inflammation is a characteristic feature of
COPD, with bacterial persistence and ongoing neutrophil recruit-
ment associated with more rapid disease progression. A discon-
nect between high neutrophil numbers and failed pathogen clear-
ance in this setting is indicative of aberrant neutrophil function, a
phenotype of considerable therapeutic interest. Peripheral blood
neutrophils from patients with GOLD stage 1–4 COPD (Table
S1) and no evidence of systemic hypoxia and respiratory failure
were studied. Patient neutrophils had impaired bacterial killing
of Streptococcus pneumoniae S14 (Figure 5A) and S. aureus
SH1000 (Figure 5B), with defective LPS survival responses (Fig-
ure 5C). Importantly, impaired survival responses could not be
rescued by glucose supplementation, indicating an intrinsic
neutrophil defect independent of glucose availability. In keeping
with a dysregulated metabolic status, COPD neutrophils had
significantly lower ATP levels at baseline when compared to
healthy controls (Figure 5D) and a reduced glycolytic response
to SH1000 (Figures 5E and 5F). Diminished glycolytic capacity
occurred despite preservation of glucose uptake with equivalent
tracing of U-13C glucose into glucose-6-phosphate (Figure 5G)
and retained expression of the dominant neutrophil glucose trans-
porter GLUT1 (Figure S6A) in unstimulated and LPS-stimulated
states. Extending our observations that neutrophils have an active
gluconeogenesis pathway that uses non-glucose substrates to
generate glycogen, and the importance of glycogen stores for
neutrophil survival, we therefore questioned whether defective
gluconeogenesis and glycogen cycling could result in these
dysfunctional neutrophil responses. Initial baseline phenotyping
of peripheral blood neutrophils revealed an impaired ability of
COPD neutrophils to increase glycogen levels in response to
LPS (Figure 5H) and to increase transcription of the key gluconeo-
genic enzyme PEPCK2 (Figure 5I) and the glycogenic enzyme
GBE1 (Figure 5J). LC-MS analysis of healthy control and COPD
blood neutrophils was then undertaken to delineate the metabolic
consequences of impaired glycogen cycling in these cells. COPD
neutrophils displayed significantly lower lactate levels with nor-
moxic culture alone and following LPS stimulation (Figure 5K).
This was associated with a decreased level of lactate in the me-
dium of COPD neutrophils cultured with LPS (Figure 5L) and
reduced levels of the PPP substrates ribose-5-phosphate (Fig-
ure 5M) and sedoheptulose-7-phosphate (Figure 5N). COPD neu-
trophils also demonstrated a failure to generate the metabolites
required for effective redox buffering capacity (NADH) (Figure 5O)
Figure 4. Glycogen Storage Capacity Dictates Neutrophil Function and Survival in Gys1loxloxMRP8-cre+/– Mice and Healthy Human Volun-
teers Exposed to Altitude-Induced Hypoxia
(A and B) Neutrophil glycogen content following 6 (A) or 4 h (B) normoxic culture in glucose-deplete media with the glutaminase inhibitor BPTES preventing
glutamine breakdown (A; n = 4) and the gluconeogenesis inhibitor MB05032 (B; n = 3).
(C–E) Assessment of apoptosis rates using flow cytometry (C) and cellular morphology (D and E) following culture in glutamine-deprived (C) or glucose-deplete
media (D and E) under conditions of normoxia and hypoxia ± LPS for 6 (D) and 20 h (C). Data shown asmean ± SEM (C and D) and fold change fromDMSO vehicle
control. n = 4.
(F and G) Neutrophils were challenged with S. aureus (SH1000) at a multiplicity of infection (MOI) of 10 and bacterial killing assessed by flow cytometry. Data
shown as fold change from DMSO (F; n = 7) and untreated (G; n = 3) controls.
(H) Glycogen content of neutrophils in the bone marrow, blood, and bronchoalveolar lavage (BAL) of untreated and 24 h post-LPS challenge of wild-type mice
(WT). n = 3.
(I) Glycogen content of circulating and BAL neutrophils of WT and Gys1 knockout mice. n = 3.
(J) Assessment of apoptosis rates using flow cytometry following 24 h of culture under standard media conditions. n = 5.
(K) In vitro challenge of BAL neutrophils with S. aureus (SH1000) (MOI:10) and bacterial killing assessed by flow cytometry. n = 3.
(L–N) Gys1lox/lox MRP8-Cre+/ knockout (GYS1 KO) and Gys1lox/lox MRP8-Cre/ WT mice were inoculated with 5 3 107 CFU of S. aureus (SH1000) and rectal
temperatures (L), total abscess CFU counts (M), and blood neutrophil counts (N) obtained 24 h post-subcutaneous infection.
(O–R) Intracellular glycogen levels (O; n = 6), UGP2 (P; n = 8) and GYS1 (Q; n = 7) relative transcript abundance, and apoptosis rates (R; n = 8) were measured in
blood neutrophils isolated from healthy human volunteers at baseline (BL) and 3 months post-altitude-induced hypoxia (PA), following culture ex vivo with LPS
and hypoxia.
Data representmean ± SEM. Statistical significance was determined by paired t tests (A, B, D–F, K, P, andQ), two-way ANOVAwith Sidak’s multiple comparisons
test (C, O, and R), one-way ANOVA with Tukey’s multiple comparisons test (C, G, and H), and unpaired t tests (I, J, and L–N). *p < 0.05, **p < 0.01, ***p < 0.005,
****p < 0.001.
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Figure 5. COPD Peripheral Blood Neutrophils Are Unable to Regulate Their Glycogen Synthesis, Resulting in Diminished Intracellular
Glycogen Stores, Defective Bacterial Killing, and Survival
(A–C) Neutrophils from healthy control subjects (HC; open black circle) or patients with COPD (COPD; open blue square) were challenged with either opsonized
serotype 14 Streptococcus pneumoniae (S14) (A; n = 7) or Staphylococcus aureus (SH1000) (B; n = 4), at a multiplicity of infection (MOI) of 10 and bacterial killing
assessed. Assessment of apoptosis by annexin V/TO-PRO-3 staining of HC and COPD neutrophils following 20 h culture (C; n = 6).
(legend continued on next page)
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and pathogen sensing responses (UDP-glucose and UDP-
GlcNAc) (Figures 5P and 5Q) (Jha et al., 2015). Finally, tracing of
U-13C glutamine into F1,6BP (Figure 5R) demonstrated that
COPD neutrophils have a diminished capacity to utilize glutamine
for gluconeogenesis.
Figure 6 summarizes the dynamic balance between neutro-
phil energy utilization and storage driven by intracellular
glycogen stores in quiescent and activated blood neutrophils,
and how this becomes uncoupled in chronic inflammatory
states.
DISCUSSION
Cellular adaptation to physiological stresses encountered within
inflamed tissues is critically dependent uponmetabolic responses
that maintain ATP and modify energy requirements. Neutrophils
are unusual in that they must rapidly access ATP to enable re-
sponses, including migration, pathogen control, and apoptosis,
that have significant energy requirements (Borregaard and Herlin,
1982). As such, they have evolved a dependence upon glycolysis
for ATP production. We have delineated the metabolic processes
that enable this metabolic specialization, allowing successful
matching of energy supply and demand through the ability of neu-
trophils to regulate autocrine energy stores in the form of
glycogen. Through cycling between gluconeogenesis and glyco-
genesis, we propose that neutrophils are able tomaintain their en-
ergy charge throughout their lifespan, even when glucose is
limited.
Initial experiments detailing the existence of multiple glucose
isotopologues with U-13C glucose tracing, and demonstrating
neutrophil expression of unidirectional enzymes required for
gluconeogenesis (PCK2 and FBP1), led us to propose that neu-
trophils can undergo gluconeogenesis. This was verified using
LC-MS tracing of heavy carbons from U-13C glutamine and pal-
mitic acid into glycolytic intermediaries and finally U-13C pyru-
vate into glycogen. The ability of neutrophils to scavenge gluta-
mine for generation of glycolytic intermediaries is particularly
important, given the relative availability of these metabolic sub-
strates at the inflamed site, as this provides a mechanism
whereby neutrophils can continue to meet energetic demands
in the absence of extracellular glucose. The capacity for limited
non-hepatic gluconeogenesis is not entirely without precedent.
In a glucose-deprived setting, cancer cells have the ability to
switch to using glutamine as a substrate and engage the early
steps of gluconeogenesis through regulation of mitochondrial
PCK2 (Vincent et al., 2015). More recently, maintenance of
CD8 T cell memory has been linked to activation of the cytosolic
form of this enzyme PCK1 (Ma et al., 2018; Vincent et al., 2015),
while loss of PCK1 has also been associated with a reduction in
TCA cycle intermediaries and pro-inflammatory macrophage
polarization. There is, however, no evidence to date suggesting
that myeloid populations other than neutrophils have the capac-
ity to undergo gluconeogenesis (Ko et al., 2018) and only a single
report demonstrating the differential regulation of glycogen and
glucose metabolism in dendritic cells (Thwe et al., 2017), indi-
cating cell-type-specific metabolic adaptations within the innate
immune response and thus the opportunity for neutrophil-spe-
cific therapeutic intervention.
We subsequently questioned how neutrophils balance energy
utilization with energy storage and the consequences for im-
mune cell function. This was explored by exposing peripheral
blood neutrophils from healthy volunteers to differing physiolog-
ical stresses (glucose depletion and hypoxia), pro-inflammatory
activation with LPS, and inhibitors of glycogen degradation.
Increased generation of glutamine-derived glycolytic intermedi-
aries together with increased gluconeogenesis fueled glycogen
deposition following LPS stimulation of neutrophils would sug-
gest that in response to a proinflammatory stimulus neutrophils
increase cycling through gluconeogenesis and glycogenesis to
maintain glycogen storage, which in turn fuels the higher energy
demands of a proinflammatory response.
Importantly, this glycogen/glucose axis is both amenable to
modulation and regulates neutrophil function. Exposing healthy
volunteers to altitude-induced hypoxia resulted in augmented
intracellular glycogen reserves in response to LPS and
enhanced neutrophil survival. The ability of cells to shunt
glucose into glycogen has previously been observed in brain
astrocytes and cancer cells (Favaro et al., 2012; Obel et al.,
2012). In hepatoma cell lines, these changes in glycogen turn-
over are sensitive to hypoxia and important for cell survival
(Pescador et al., 2010). More broadly, glycogen utilization has
also been linked to cancer cell proliferation, abrogation of pre-
mature senescence (Rousset et al., 1979), and optimal func-
tioning of the PPP (Favaro et al., 2012). The impact of hypoxia
in this setting is of considerable interest given hypoxia is an
important hallmark of the tumor microenvironment. This is
(D) Relative of ATP abundance of freshly isolated neutrophils from HC and COPD using RP-HPLC (reversed-phase high-performance liquid chromatography).
HC, n = 4; COPD, n = 6.
(E and F) Seahorse quantification of ECAR of healthy and COPD peripheral blood neutrophils exposed to SH1000 at an MOI of 10, 25, and 50. n = 4.
(G) U-13C glucose incorporation into glucose-6-phosphate/fructose-6-phosphate (G6P/F6P) following 4 h of culture in U-13C glucose containing media under
normoxia in the presence (filled symbol) and absence (open symbol) of LPS. n = 5.
(H) Glycogen content of HC and COPD neutrophils cultured in glucose-replete and glucose-deplete media for 6 h in the presence and absence of LPS. n = 7.
(I and J) Relative transcript abundance of the gluconeogenic gene PEPCK2 (I; n = 7, unstimulated; n = 9, LPS) and glycogen synthesis pathway geneGBE1 (J; n =
7) in HC and COPD neutrophils cultured for 6 h in the presence and absence of LPS normalized to b-actin expression.
(K–Q) Healthy control and COPD peripheral blood neutrophils were cultured in U-13C glucose containing media for 4 h under normoxia in the presence and
absence of LPS. Total intracellular lactate (K; n = 5), medium lactate (L; n = 5), ribose5P/xylulose5P (M; n = 5), sedoheptulose7P (N; n = 5), NADH (O; n = 4), UDP-
glucose (P; n = 5), and UDP-GlcNAc (Q; n = 5) were measured using LC-MS and normalized to protein content. Fold change was determined relative to the paired
unstimulated HC control (M).
(R) Healthy control and COPD peripheral blood neutrophils were cultured in U-13C glutamine containing media for 4 h under normoxia and total labeled F1,6BP
measured using LC-MS. n = 6.
Data are expressed as individual data points with mean ± SEM. Statistical significance was determined by paired t tests (A–D and H–R) or two-way ANOVA with
Sidak’s multiple comparisons test (E and F). *p < 0.05, **p < 0.01.
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further strengthened by the observation that glycogen biosyn-
thetic enzymes (GYS1, GBE1, and UGP2) are themselves regu-
lated at a transcriptional level by hypoxia (Pescador et al.,
2010). In a disease setting, defective glutamine utilization for
gluconeogenesis and reduced glycogen shuttling result in
insufficient glycogen stores to fuel effective immune responses
and generate pathogen-sensing sugars, with consequences for
neutrophil survival and bacterial killing. Moreover, in vivo study
of neutrophils deficient in the glycogen synthesis enzymeGYS1
provides direct evidence that neutrophil glycogen fuels effec-
tive host immunity, with impaired bacterial control observed
in Gys1loxlox MRP8-Cre+/ transgenic mice.
Limitations of Study
Our study demonstrates that neutrophils have adapted to use
multiple metabolic substrates to generate energy stores in the
form of glycogen, which are dynamically regulated by both
gluconeogenesis and glycogenesis. Increased glycogen shunt-
ing enables neutrophils to meet the higher metabolic demands
of a pro-inflammatory response. Conversely, failure to replenish
or access these glycogen stores results in metabolic exhaustion
and dysfunctional neutrophil responses. What underpins the
defective glycogen cycling we observe in neutrophils isolated
from patients with chronic inflammatory disease is currently un-
known, and a limitation of the work undertaken to date.
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Figure 6. A Summary of the Observed Meta-
bolic States of Quiescent, LPS Stimulated,
and COPD Neutrophils
A diagram showing the metabolic states of resting
(A), stimulated (B), and COPD (C) neutrophils
showing increased glycolytic activity and glycogen
synthesis in response to LPS and defective
glycogen cycling and glycolysis in COPD. Genes
identified to actively regulate neutrophil glucose
transport (Glut1), gluconeogenesis (GNG) (Fbp1
and Pck2), glycogenesis (Gys1, Gbe1, and Ugp2),
and glycogenolysis (Pygl) are highlighted in red.
Arrow thickness indicates the relative flux through
metabolic pathways with glycogenolysis and
glucose oxidation highlighted in blue and glyco-
genesis and gluconeogenesis in green.
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Moreover, how neutrophil metabolic responses are reprog-
rammed and retained within circulating populations over time re-
quires further study. Nonetheless, we propose that this meta-
bolic specialization of neutrophils could allow selective
targeting of glycogen cycling to optimize the efficacy of neutro-
phil host responses and thus facilitate inflammation resolution.
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STAR+METHODS
KEY RESOURCES TABLE
RESOURCE AVAILABILITY
Lead Contact
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, sarah.
walmsley@ed.ac.uk
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Anti-PCK2 antibody Abcam Cat# ab70359; RRID: AB_1952317
Anti-FBP1 antibody Abcam Cat# ab109020; RRID: AB_10865049
Anti-p38 MAPK Antibody New England Biolabs Cat# 9212S; RRID: AB_330713
Anti-Phospho-Glycogen Synthase (Ser641) Antibody Cell Signaling Cat# 3891S; RRID: AB_2116390
Anti-PYGL antibody Abcam Cat# ab198268-100ul
Bacterial and Virus Strains
Staphyloccus aureus SH1000 Prof Simon Foster N/A
Streptococcus pneumoniae S14 Prof David Dockrell N/A
Biological Samples
Healthy adult blood neutrophils Isolated from healthy volunteers N/A
COPD adult blood neutrophils Isolated from COPD patients N/A
Chemicals, Peptides, and Recombinant Proteins
Fructose-1,6-bisphosphatase-1 Inhibitor Cambridge BioScience Cat#18860-5mg-CAY
GLUTAMINASE INHIBITOR II BPTES Merck Life Sciences UK Cat#5300300001
AMYLOGLUCOSIDASE FROM ASPERGILLUS
NIGER LYOPH. 70 U/MG
Merck Life Sciences UK Cat#10115-1G-F
CP-91149 Sigma-Aldrich Cat#PZ0104-5M
3-Mercaptopicolinic acid (HCl) Cambridge bioscience Cat#20895-100 mg-CAY
MB05032 (Tocris Bioscience) Bio-Techne Cat#6618/10
Etomoxir Abcam Cat#ab144763-2mg
LPS from E. coli, Serotype R515 (Re) (TLRgrade) Enzo life Sciences Europe Cat#ALX-581-007-L002
Critical Commercial Assays
EasySep Human neutrophil Isolation Kit Scientific Laboratory Supplies Ltd Cat#17957
Glycogen assay kit Sigma-Aldrich Cat#MAK016
FBP1, Homo_sapiens PrimeTime Std qPCR Assay Integrated DNA Technologies Cat#Hs.PT.58.1719755
GYS1, Homo_sapiens PrimeTime Std qPCR Assay Integrated DNA Technologies N/A
ACTB, Homo_sapiens PrimeTime Std qPCR Assay Integrated DNA Technologies Cat#Hs.PT.39a.22214847
PYGL (phosphorylase, glycogen, liver), Hs00958087_m1 Applied Biosystems Cat#4331182
SLC2A1 Homo_sapiens PrimeTime Std qPCR Assay Integrated DNA Technologies Cat#Hs.PT.58.25872862
PCK2 Homo_sapiens PrimeTime Std qPCR Assay Integrated DNA Technologies Cat#Hs.PT.58.19439369
UGP2 Homo_sapiens PrimeTime Std qPCR Assay Integrated DNA Technologies Cat#Hs.58.39665284
Seahorse XF Glycolytic Rate Assay Agilent Technologies Cat#Cat#103344-100
Experimental Models: Organisms/Strains
Gys1lox/lox MRP8-Cre+/ mice In this paper N/A
C57BL/6JOlaHsd Jackson Laboratory N/A
Software and Algorithms
GraphPad Prism v.8 GraphPad Software GraphPad Prism; RRID: SCR_002798
Thermo Xcalibur Thermo Fisher Scientific Thermo Fisher Scientific
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Materials Availability
The mouse line (Gys1lox/lox MRP8-Cre+/) generated in this study is available from the Lead Contact upon request.
Data and Code Availability
This study did not generate/analyze datasets/code.
EXERIMENTAL MODEL AND SUBJECT DETAILS
Subject Details
Peripheral venous blood neutrophils were isolated from healthy volunteers with written informed consent as approved by the CIR
Blood Resource Management Committee (AMREC 15-HV-013) in Edinburgh and the Commisie Medische Ethiek UZ KU Leuven
in Belgium (total number of participants 67 aged between 20-70 years, mean age range 31-40, Gender M 27: F 40). Peripheral venous
blood neutrophils were also isolated from patients with COPD in accordance with local ethics (REC reference: 15/SS/0095). Patient
details are shown in Table S1 (total number of participants 24 aged 40-76 years, mean age 58.7, GenderM 10: F 14). Exclusion criteria
included history of anemia, pregnancy or breast-feeding, Diabetes Mellitus, CKD, hepatic failure, immunosuppression and febrile
illness within the last two weeks. COPD patients were matched to healthy non-smoker control donors ± 5 years of age wherever
possible (total number of participants 18 aged between 20-70, mean age range 41-50, Gender M 8: F 9). Negative magnetic selection
(STEMCELL Technologies, Vancouver) was carried out to further purify the neutrophils and consistently demonstrated purity of
over 98%.
High Altitude Research Participants
12 healthy participants aged 19-22 years (mean age 20, Gender M 6:F 6) were recruited from the University of Edinburgh student
community. Exclusion criteria included previous hospital admission for asthma, significant cardio-respiratory disease, regular car-
diovascular medications, pregnancy, smoking and previous exposure to high altitude (defined as > 2500 m). Ethical approval was
granted by the ACCORD Medical Research Ethics Committee (REC reference: 17-HV-030) and all participants provided informed
written consent. Data were collected at sea level, during baseline and post-expedition testing, and at 4,700 m on the APEX 5 expe-
dition. Subjects flew into La Paz, Bolivia (3,600m)within a 12 h period and after acclimatizing for four days, ascended 90min by bus to
Huayna Potosı́ base camp (4,700 m) for seven days before returning to La Paz. Mean peripheral blood oxygen saturation (SpO2) was
measured daily using pulse oximetry (SantaMedical, Tustin). In all control and patient cohorts bothmale and female participantswere
included and matched where possible, small sample sizes precluded any further study of the influence of sex.
Isolation of Human Neutrophils
Neutrophils were isolated from sodium citrate anticoagulated blood as previously described using dextran sedimentation and
discontinuous percoll gradients (Walmsley et al., 2005).
Generation of Gys1lox/lox MRP8-Cre+/– Mice
Gys1 lox/lox mice (Duran et al., 2013) were crossed with the previously reported neutrophil specific cre driver Mrp8 (Finisguerra et al.,
2015) to generate Gys1lox/lox MRP8-Cre+/ mice on a C57BL/6JOla genetic background. Both male and female littermates were
used from ages 6-12 weeks old with Gys1lox/lox MRP8-Cre/mice and wildtype C57BL/6JOla sex matched or litter mate controls.
Study Approval
Animal experiments were conducted in accordance with the UK Home Office Animals (Scientific Procedures) Act of 1986. All animal
studies were approved by The University of Edinburgh Animal Welfare and Ethical Review Board. 6-12 week old male and female
mice were used for experiments. Mice were housed in IVC cages under 12 h light/darkness cycles and controlled temperature
(20-23C) in accordancewith UKHomeOffice guidance. All mice used for experiments were healthy with quarterly and annual testing
carried out in accordance with FELASA 2014 Guidelines, using a mixture of environmental, random colony samples and sentinel
testing by serology and PCR. Mice had free access to food (Special diets service rat and mouse number 1 maintenance food RMI
(P) 801151) and water.
METHOD DETAILS
Neutrophil Culture
Neutrophils were cultured at 5million cells/mL for 2-20 h at 37C, in normoxia (21%O2, 5%CO2) or hypoxia (1% (3kPa) O2, 5%CO2)
in two types of pre-equilibrated RPMI media 1640 with 10% fetal bovine serum (FBS) (GIBCO) and 1% Penicillin/Streptomycin,
differing in the presence or absence of glucose. In the absence of glucose, dialyzed glucose-free FBS was used. To study the effects
of stimulation and metabolic inhibitors, neutrophils were cultured with (100ng/mL) LPS E.coli serotype R515 (Enzo), CP-91149
(Sigma-Aldrich), 2-deoxyglucose (Sigma-Aldrich), Oligomycin A (Sigma-Aldrich) and Etomoxir (10uM) (CNIO Carlos III
Therapies) (Raud et al., 2018; Yao et al., 2018), Fructose-1,6-bisphosphatase-1 Inhibitor (FBP1i) (Cambridge Bioscience),
MB05032 (Tocris Bioscience), 3-Mercaptopicolinic acid (HCl) (3-MPA) (Cambridge Bioscience), Glutaminase Inhibitor II, BPTES
(MERCK Chemical).
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Radioactive Flux Assays
3H-Glycolytic Flux
Purified peripheral blood neutrophils (2.5 x106) were incubated for 6 h in RPMI 1640 medium (supplemented with 5.5 mM unlabeled
glucose, 10% FCS and 1% Penicillin/Streptomycin) containing 0.4 mCi/mL [5-3H]-D-glucose (Perkin Elmer). Cells were pelleted
(420 g for 10 min) and supernatant transferred into glass vials containing 12% perchloric acid sealed with rubber stoppers. 3H2O
was captured in hanging wells containing a piece of Whatman paper soaked with H2O over a period of 48 h at 37
C to reach satu-
ration. Radioactivity in the Whatman paper was determined by liquid scintillation counting.
3H- Fatty Acid Flux
2.5 x106 were incubated 6 h in RPMI 1640 medium (supplemented with 5.5 mM unlabeled glucose, 10% FCS and 1% Penicillin/
Streptomycin) containing 0.4 mCi/mL [-3H]-D-palmitic acid (Perkin Elmer).
14C-glucose Oxidation
The contribution of the TCA cycle to total glucose utilization was measured as 14CO2 release formation both in the TCA cycle and
oxidative pentose phosphate pathway using 0.55 mCi/mL [6- 14C]-D-glucose. Following a 6 h incubation in RPMI 1640 medium (sup-
plemented with 5.5 mM unlabeled glucose, 10% FCS and 1% Penicillin/Streptomycin) containing 0.55 mCi/mL [6- 14C]-D-glucose,
2.5 x106 cells were lysed using 250 mL of 12%Perchloric acid.Wells were immediately covered with a piece of 1x hyamine hydroxide-
saturated Whatman paper and overnight absorption of 14CO2 released was performed at room temperature. Radioactivity in the
Whatman paper was measured using scintillation counting.
Energy Status and Energy Charge
A total of 5x106 purified human peripheral blood neutrophils were harvested in 100 mL of ice-cold 5% PCA supplemented with 1 mM
EDTA. ATP, ADP and AMP levels were measured using ion-pair RP-HLPC. Thereafter, samples were centrifuged for 10 min at
13000 g and the supernatant neutralized with K2CO3. Following perchlorate precipitation, the supernatant was injected on a
4.6 3 150-mm, 5-mm particle size C-18 HPLC column at a rate of 1 mL/min, 100% buffer A from 0 to 5 min, 100% buffer A to
100% buffer B from 5 to 20 min, 100% buffer B from 20 to 31 min for column re-equilibration (buffer A: 25 mM NaH2PO4,
0.385 mM tetrabutylammonium, pH 5; buffer B: 10% (v/v) acetonitrile in 200 mM NaH2PO4, 0.385 mM tetrabutylammonium, pH
4). Phosphorylated nucleotidesweremonitored at 260 nm. The energy charge was expressed as ([ATP] + 1/2 [ADP] / [ATP] + [ADP] +[-
AMP]) and the energy status of the cells as the ratio of ATP to ADP content.
LC-MS
Ultrapure neutrophils were cultured in the presence of 5.5 mM. U-13C glucose or 100 mM U-13C palmitate for 4 h and 2mM U-13C
glutamine for 2,4 and 6 h. 2 0.5x106 cells were harvested in 100 mL of 80%methanol. Measurements of relative levels of analyte abun-
dance and 13C incorporation into glycolytic intermediates were performed using a Dionex UltiMate 3000 LC System (Thermo Scien-
tific) coupled to aQExactive OrbitrapMass Spectrometer (Thermo Scientific) operated in negativemode. Practically, 25 mL of sample
was injected on a SeQuant ZIC/pHILIC Polymeric column (Merck Millipore). The gradient started with 10% solvent B (10 mM NH4-
acetate inmqH2O, pH 9.3) and 90% solvent A (acetonitrile) and remained at 10%Buntil 2min after injection. Next, a linear gradient to
80% Bwas carried out until 29 min. At 38 min, the gradient returned to 40%B, followed by a decrease to 10% B at 42 min. The chro-
matography was stopped at 58min. The flowwas kept constant at 100 ml/min, and the column was kept at 25C throughout the anal-
ysis. The MS operated in full scan–SIM mode using a spray voltage of 3.2 kV, capillary temperature of 320C, sheath gas at 10.0,
auxiliary gas at 5.0. AGC target was set at 1e6 using a resolution of 140,000, with a maximum IT of 500 ms. Data collection and anal-
ysis were performed using Xcalibur Software (Thermo Scientific). Total metabolite abundance is shown as a measure of both unla-
beled 12C isotopologues and all other mass isotopologues corresponding to the analyte of interest. Isotope correction was carried
out as previously described using an in-house software tool.
LC-MS Analysis of Glucose Generated from Hydrolysed Glycogen
Neutrophils (10 x106) were cultured in U-13C pyruvate for 8 h under normoxia and hypoxia. The cells were washed with saline and
lysed by boiling for 15 min in 30% KOH. Glycogen was precipitated using ice cold 100% ethanol and washed a further two times.
Following the evaporation of residual ethanol and resuspension in water the glycogen was hydrolysed using amyloglucosidase
(Merck Life Sciences UK). Acetonitrile:methanol:water 40:40:20 was added to the samples and samples analyzed by LC-MS.
Measurement of Intracellular Glycogen Stores
Radioactive Assays for Measuring Glycogen Content
Neutrophils (5 3 106) were culture with U-14C glucose or U-14C lactate for 6 h in the absence and presence of LPS under normoxia
and hypoxia. The cells were washed 5 times in ice-cold PBS and lysed in 30% KOH by boiling for 15 min. An aliquot of the homog-
enate was spotted onto Whatman paper and the glycogen precipitated by immersing the paper in ice-cold 66% ethanol (v/v).
Following two washes with ethanol, radioactivity in the Whatman paper was measured using scintillation counting.
Fluorimetric Assay
1 3 106 human neutrophils were lysed in 200 mL ice-cold H2O and boiled for 10 min at 95 degrees; lysates were centrifuged at
18,000 g at 4C for 10 min to remove cell debris and snap frozen. Glycogen content was measure using a fluorimetric assay
(Sigma-Aldrich).
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Extracellular Acidification Rate (ECAR) Quantification Using Seahorse
Neutrophils were resuspended in XF assay media at a concentration of 3x106/mL onto a XF24 cell plate pre-coated with Cell-Tak
(Corning). Cells were stimulated with Staphylococcus aureus (SH1000) at MOI 10, 25 and 50. The ECAR were measured at intervals
of 7 min over a 90-min cycle using a Seahorse XF24 (Seahorse Bioscience USA).
Apoptosis Assay
Neutrophil apoptosis following 20 h of culture was measured by flow cytometry of cell stained with Annexin V PE and the nuclear dye
TO-PRO-3 (Molecular Probes, Thermo Fisher). Flow cytometric measurements were performed using a four-color FACSCalibur flow
cytometer (Becton Dickinson).
RNA Isolation and Relative Quantification
RNA was isolated from neutrophils using the mirVana total RNA isolation protocol (Ambion, Thermo Fisher), DNase treated and
reverse transcribed using AMV reverse transcriptase with random primers (Promega). TaqMan gene expression assays (Applied Bio-
systems, Thermo Fisher) and PrimeTime qPCR Probe Assays (IDT) were used for relative quantification of cDNA using SDS 2.4
(Thermo Fisher) and normalized to ACTB expression.
Bacterial Killing Assay
Neutrophils were infected for 90 min with an MOI of 10. After the killing of extraceullar bacteria for 30 min with either Gentamycin
(20 mg/mL) and Benzylpenicillin (40 units/mL) when using serotype 14 Streptococcus pneumoniae (S14) or Gentamycin (20 mg/
mL) and Vancomycin (10 mM) when using Staphylococcus aureus (SH1000), the numbers of internalised bacteria at times 0 and
3 h were measured.
Inhibition of Glutaminolysis (BPTES) and Gluconeogenesis (3-MPA, FBPi) and Bacterial Killing Assay
Neutrophils were cultured for 4 h in glucose-deprived media with the inhibitors and infected with Staphylococcus aureus SH1000 for
60 min with an MOI of 10. After the killing of extraceullar bacteria for 30 min with either Gentamycin (20 mg/mL) and Vancomycin
(10 mM), the number of internalised bacteria at times 0 and 2 h were measured.
Protein Extraction and Western Blotting
Neutrophil whole cell lysates were prepared with Laemmli buffer containing PI cocktail (protease inhibitor), PhosSTOP, PMSF (phe-
nylmethylsulfonylfluoride) andDFP (Diisopropyl fluorophosphate). Following lysis sampleswere boiledwith 2x loading buffer contain-
ing SDS. Immunoblotting was performedwith antibodies against glycogen synthase (total), phosphoglycogen synthase (Ser641) (Cell
Signaling), glycogen phosphorylase (liver form) (Abcam), phosphoenol pyruvate carboxykinase 2 (PCK2) (Abcam), fructose 1,6 bi-
sphosphatase 1 (FBP1) (Abcam) and HRP-conjugated secondaries: anti-mouse IgG (Cell Signaling Technology) and goat anti-rabbit
IgG (Dako). Total P38 was used as a loading control.
In Vivo Staphylococcus aureus Skin Abscess Model
Mice were injected subcutaneously with live stationary phase Staphylococcus aureus (SH1000) at 5x107 CFU. At 24 h, rectal tem-
peratures and abscess areas were recorded, mice anesthetized and exsanguinated, and tissue processed for CFU counts.
QUANTIFICATION AND STATISTICAL ANALYSIS
Data represent mean ± SEM from at least three independent experiments.
Significance was determined by paired 2-tailed t tests unless otherwise stated. All statistical tests were performed with Prism 7
software (GraphPad Software) using unpaired t tests, paired t tests, one-way or two-way ANOVA with Tukey’s multiple comparisons
test, two-way ANOVA with Sidak’s multiple comparions test. Statistical parametric analyses were performed following confirmation
of normal distribution of the data. *p < 0.05 was considered as statistically significant. **p < 0.01, ***p < 0.005, ****p < 0.001. Statistical
parameters are highlighted by * values in each figure with details provided in the associated figure legends.
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